CDKN2A and head and neck squamous cell carcinoma: In HPV-negative HNSCC, activating mutations in classic oncogenes are relatively rare, and most genetic alterations are in tumor suppressor genes such as p53 and cyclin-dependent kinase inhibitor 2A (CDKN2A).